Heart FailureRETURN-001NCT02387190
REmoTe TelenURsiNg on Lung Function of Heart Failure Outpatients
A study testing Telenursing monitoring in people with Heart Failure, run by Federal University of Bahia at 1 site in Brazil.
Trial summary
Pulmonary dysfunction presented in patients with heart failure is observed as a decrease of maximal aerobic capacity compared to healthy people. Lung function deterioration manifests, in the presence of muscle fatigue and dyspnea on exertion, loss of functional capacity, and activities limitation of daily living. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure
- What is being tested?
- Telenursing monitoring
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 156 participants
- Where
- 1 siteBrazil
- Study dates
- Nov 2013to Mar 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- With prior medical diagnosis of heart failure with functional class I, II or III, in accordance to New York Heart Association (NYRA)8.
- In regular follow-up for at least six months at the study site. Regular follow will be considered when in the period of six months the individual attend at least 2/3 of the scheduled appointments of outpatient unit and 100% of run-in period appointments.
- With dyspnoea or spirometric volumes evidencing deterioration of lung function.
- With cognitive conditions to be interviewed.
- With no medical restrictions to perform spirometry testing and six-minute walk test.
- With clinical control of the heart failure.
Who cannot join
- With psychiatric disorders;
- Who do not meet eligibility criteria after run-in period;
- With severe acute or chronic pulmonary disease;
- Who change clinical parameters during the data collection (severe dyspnoea, peripherical oxygen saturation below 95%).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effectiveness of Telenursing Program on Lung Function of Heart Failure Patients: a Randomized Clinical Trial Protocol
Pulmonary dysfunction presented in patients with heart failure is observed as a decrease of maximal aerobic capacity compared to healthy people. Lung function deterioration manifests, in the presence of muscle fatigue and dyspnea on exertion, loss of functional capacity, and activities limitation of daily living. Those manifestation influence the perception of quality of life of patients1.
Patients with heart failure need to develop changes in lifestyle and daily activities aiming to maintain clinical control and prevent the onset of complications and disabilities. If these changes are not often performed, they might carry bigger burden to for the individual and their family and for the healthcare system due to increasing of morbidity and mortality between those patients2.
Read more
Systematic reviews conducted in developed countries (USA3, UK4 and Canada5) and developing countries (Colombia6) have shown that telehealth can produce positive effects in individuals with chronic diseases as heart failure. This kind of intervention seems to be effective in preventing hospitalizations and non-elective emergency visits.
In Brazil, telenursing is still a non-standardized and non-diffused intervention. In this perspective, telenursing represents soft new tools to provide quality care. It certainly allows the orientation and training of patients, the permanence of them at home, reduces unnecessary hospitalization. Additionally, this intervention, allows the management of nursing time and strengthens their professional autonomy7.
The principal aim of this study is to describe the protocol to be used in MRE study. The objective of MRE trial is to test the hypothesis that telenursing contributes to the improvement in lung function over the medium term, in patients with heart failure under continuous education.
Read the detailed description
METHODS STUDY DESIGN It will be a blinded- controlled-randomized clinical trial in parallel-group, with six months follow-up. The trial protocol will be performed in referral outpatient center that accompany patients with heart failure. This unit is part of the public health system in the city of Salvador - Bahia, the second largest city in Northeast of Brazil. The Brazilian health system is one of the largest public health systems in the world. Ensures full access, universal and free to the entire population of the country. Bolstered by a broader concept of health, the health system was created in 1988 by the Brazilian Federal Constitution, to be the health system of more than 180 million Brazilians.
Run-in
The run-in period will last 15 days. After the run-in, eligible patients will be part of the study, according the following criteria:
- To participate in a telenursing education program;
- To fill-in a diary of symptoms and signs, daily;
- To receive calls from the research team weekly;
- To have attendance at appointment between window of 15 days before or after the scheduled date;
- To be predisposed to performing spirometry testing, six-minute walk test, pulse oximetry, electrocardiography, and to respond questionnaires about quality of life and scales of dyspnoea.
Wash out
After beginning the project, patients who present the following criteria must be excluded:
- Pregnancy;
- Hospitalization for more than 30 days;
- Do not attend monthly visit inside the search window of 15 days before or after the scheduled date;
- To change of residence address among states that preclude attendance at scheduled visits;
- Death;
- To discharge outpatient clinic of the Hospital of study;
- Subsequent diagnostic of acute or chronic respiratory disease or other physical/mental condition that makes it impossible to participate in the study;
- To Cease to participate in telenursingprogram or that study.
RANDOMIZATION
The sample size calculation was performed in Sealed Envelope TM program. 156 patients will be needed (78 per group), using the following indicators: confidence level 95%, 5% maximum error permitted, statistical power of 90% for detecting elevation of the primary endpoint by 12% in the experimental group. After applying the inclusion and exclusion criteria, two groups will be sourced from the randomization and will be allocated into case group and control group without replacement. All subjects included will be assigned a three-digit sequential number (eg. 000-999). These numbers will be fed into groups of four patients with similar characteristics. After that, blok size randomization will be procedure in specific software (www.randomization.com).
INTERVENTIONS The control group will receive standard treatment and monitoring for heart failure from the ambulatory staff where the study will be performed, including pharmacotherapy and health education, as recommended by the health team. The intervention group will receive the standard treatment and ongoing follow-up as well as monitoring by telenursing for a period of 6 months (24 weeks).
The application of remote nursing monitoring program shall establish contact with the participants for six months, through weekly telephone contacts on days and times to be accorded between them. We expected duration of 5 to 10 minutes per call. The team that performs the intervention will explain the content of foreseen contacts with educational approach, allowing the participant a moment to comment and clarification of final questions.
After conclusion of the study, the control group also will receive telenursing intervention if it is proven benefits through this study. The protocol for telenursing intervention deployed can continue in the specialized outpatient clinic and other chronic diseases programs, if proven their benefit.
Implementation of the Program of Telenursing The program of telenursing will consist in weekly contact with patients with heart failure with functional class I, II and III. For the development of telenursing, it will be distributed to the study staff a protocol for remote monitoring practices in nursing and a form of individualized remote monitoring (appendix A and B). Intervention group will be receive educational and support materials (educational booklet and diary of signs and symptoms).
The protocol for telenursing allows the realization of standardized professional contacts with the patient and educational approach It is possible through questions and answers coded, that indicate the need for educational intervention or reinforcement of appropriate health behavior.
The telenursing program protocol is based on: 1) Contact the patient by telephone, weekly; 2) Distribution and explanation of the educational booklet; 3) Filling a diary of symptoms and signs; 4) Record, management and markdown visits in case of non-elective visits, hospitalization or fatal episodes. Also, the following aspects shall be observed: help requests associated with illness, adaptations for living with the disease, effects of drugs in daily life, availability of financial resources for disease management, self-image; emotional and social support.
The protocol is individualized according to the needs identified in the monthly consultation and/or weekly contact for telenursing calls. The protocol addresses the themes: information of health education about the pathology; monitoring the signs and symptoms; adherence to treatment; healthy eating and weight control; breathing exercises; cardiovascular and pulmonary risk factors; physical, occupational and sexual activity; emotional and social support. It functions as a guiding instrument for telenursing, and it is useful in the clinical management of diseases, improvement of self-care, strengthening communication and humanization in relations between professionals and users of health services.
These items will be addressed in alternate calls to avoid wear and loss of information over the phone. Before finalizing the calls, will be offered the individual a moment to express doubts or make other settings regarding the intervention. The nurse is expected to write a report at the end of the calls, by checking the form of individual remote monitoring. All calls will be recorded through Skype and MP3 Skype Recorder software.
The educational booklet containing information about the heart failure and a diary of symptoms and signs will be distributed to the participants, being nurse attribution explain it to them. The booklet developed is a support material for conducting health education by telenursing, illustrated, aimed at answer typical questions, easy to handle and transport, simple visual communication, including to be accessible to individuals with limited understanding of written language. It is a suitable material for the use of the individual as well as the assistance of parents, family members, caregivers and other health professionals and students.
Moreover, after the first contact, will be developed an intervention plan for each individual, according to the needs identified after analysis of medical records and for the nursing consultation. The plan may be modified according to the needs that are identified through the telenursing calls.
Procedures BASELINE: First a baseline period will be held in which, for all individuals enrolled in the study. Following questionnaires will be applied: sociodemographic and clinical characterization formulary; quality of life (Minnesota Living with Heart Failure Questionnaire - MLHFQ); Baseline Dyspnoea Index by Mahler; and electrocardiogram will be performed. When all participants pass through the baseline period, will be preceded randomization and implementation of Visit 01.
Also in this period, a pilot of the telenursing will be made, in which seven study participants will undergo intervention in order to identify necessary changes and adjustments.
VISIT 01 (start of run-in):
For both groups: Application of structured interviews for data collection of socio-demographic and clinical characterization formulary; Application of quality of life questionnaire (MLHFQ); The questionnaire of Baseline Dyspnea Index by Mahler; Conducting pulmonary function test spirometry by a technician certified by the Brazilian Society of Pulmonology; Achievement Test six-minute walk; Measurement of clinical data (pulse oximetry, electrocardiogram, measurement of anthropometric data).
Intervention group: will be explained and distributed a educational booklet and a journal of signs and symptoms. Remote monitoring procedures with nursing continuing education will be explained, collecting best times of contact, collecting phones (personal, neighbors, to run errands, pay phone in the street of residence and mobile phone). On this same visit individuals will be informed of the weekly telephone monitoring and monthly outpatients seen for six months.
Will be provided a standardized health Education for the control group and the intervention group.
VISIT 02, 03, 04, 05:
For both groups: in the days of their regular attendance in the ambulatory will be held: standardized education; reviewed medical clinic (the regular ambulatory); the questionnaires and scales (MLHFQ and Baseline Dyspnoea Index Mahler).
Intervention group: The sessions once a month will be held during the six months of data collection. There will be continuity of telenursing directed to continuing education, weekly.
VISIT 06: all related procedures will be carried out in other visits and additionally walk test six minutes, spirometry, electrocardiogram and pulse oximetry.
ASSESSMENT
- Sphygmomanometer - Brand: Missouri.
- Electrocardiograph - Brand: EMAI - Model: 3-channel, 12 simultaneous leads, Graphic Display: LCD 12.8 x 6.4 cm, 12 Outlets EX03.
- Portable Spirometer for Lung Function Assessment, Brand: KOKO MOE FERRARIS USB.
- Stethoscope - Brand: Missouri
- Pulse Oximeter - Brand: Oxilife, Model: Plus Cmos Drake
- Notebook, Intel Core i5-3210M processor 2.5 GHz, 6GB Memory, 750GB HD, 14-inch LED screen.
- Headphone - Brand: Trust Model: Quasar 16904.
STATISTICAL ANALYSIS PLAN Descriptive statistics will be used to characterize the individuals search. The analysis of continuous variables will be through measures of central tendency and dispersion; categorical variables will be analyzed using proportions. The difference between proportions will be calculated using the chi-square test. Association tests will be performed. For correlations, the Pearson or Spearman tests depending on the normality of information or number of empty cells are proceeded. Additionally, the risk factors are analyzed according to the cutoff score of quality of life. We will use multivariate linear regression to verify association between risk factors and QoL. FIT equations will be done. There will be also analysis by protocol and by intention to treat. Analyzes stratified by age also compose the statistical plan. The information collected will be fed into a database and analyzed using SPSS 20.0 software (Statistical Package for Social Sciences). Statistically significant values with an interval of confidence greater than or equal to 95% will be considered.
- Conditions
- Heart Failure
- Being tested
- Telenursing monitoring
- Keywords
- Heart Failure, Lung function test, Telenursing, Morbidity, Mortality, Quality of life
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telenursing monitoringOther
The telenursing program protocol is based on:
- Contact the patient by telephone, weekly;
- Distribution and explanation of the educational booklet;
- Filling a diary of symptoms and signs; 4) Record, management and markdown visits in case of non-elective visits, hospitalization or fatal episodes. Also, the following aspects shall be observed: help requests associated with illness, adaptations for living with the disease, effects of drugs in daily life, availability of financial resources for disease management, self-image; emotional and social support.
| Study group | Role | What they receive |
|---|---|---|
| Telenursing monitoring | Experimental | The protocol for telenursing allows the realization of standardized professional contacts with the patient and educational approach It is possible through questions and answers coded, that indicate the need for educational intervention or reinforcement of appropriate health behavior.1) Contact the patient by telephone, weekly; 2) Distribution and explanation of the educational booklet; 3) Filling a diary of symptoms and signs; 4) Record, management and markdown visits in case of non-elective visits, hospitalization or fatal episodes. Also, the following aspects shall be observed: help requests associated with illness, adaptations for living with the disease, effects of drugs in daily life, availability of financial resources for disease management, self-image; emotional and social support. Receives: Other: Telenursing monitoring |
| Control group | No intervention | Placebo is considered as standardized education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lung function volumes
Evaluation will be done in the V6 compared to V1, only. Baseline has no spirometry test
Measured: Expected average of 6 months
Secondary outcomes (4)
Related quality of life
Minnesota living with heart failure questionnaire
Measured: Expected average of 6 months
Functional capacity
Functional capacity will be evaluated using Six-minutes walking test. Visits are done monthly (avarage)
Measured: Expected average of 6 months
Morbidity
Telenursing monitoring occurs every week during six months in the intervention group (24 weeks)
Measured: Weekly during telenursing monitoring (Expected average of 6 months)
Mortality
Telenursing monitoring occurs every week during six months in the intervention group (24 weeks)
Measured: Weekly durng telenursing monitoring program (Expected average of 6 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2015 (estimated)
- Study startNov 2013
- Primary completionApr 2015
- Study completionMar 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 156 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Federal University of Bahia
- Sponsor type
- University, hospital or other
- Collaborators
- Fundação de Amparo à Pesquisa do Estado da Bahia
- Responsible party
- Principal investigator, Carolina de Souza-Machado, Federal University of Bahia
- Investigators
- Carolina Souza-Machado, PhD, Study chair, Federal University of BahiaCarolina Santos, NP, Principal investigator, Federal University of BahiaBárbara Sueli Moreira, NP, Principal investigator, Federal University of BahiaLoyane Stenzel, NP, Principal investigator, Federal University of Bahia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02387190
- Sponsor's protocol ID
- RETURN-001
- Other IDs
- RETURN-001
- Acronym
- RETURN-001
- Status last verified
- Feb 2016
- First submitted
- 14 May 2014
- Last updated
- 12 Feb 2016
- Results posted
- No
- Data monitoring committee
- No
Publications
Rodriguez-Gazquez Mde L, Arredondo-Holguin E, Herrera-Cortes R. Effectiveness of an educational program in nursing in the self-care of patients with heart failure: randomized controlled trial. Rev Lat Am Enfermagem. 2012 Mar-Apr;20(2):296-306. doi: 10.1590/s0104-11692012000200012. English, Portuguese, Spanish.
PubMed 22699730Riley JP, Gabe JP, Cowie MR. Does telemonitoring in heart failure empower patients for self-care? A qualitative study. J Clin Nurs. 2013 Sep;22(17-18):2444-55. doi: 10.1111/j.1365-2702.2012.04294.x. Epub 2012 Nov 27.
PubMed 23185992
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Telenursing Program on Lung Function of Heart Failure Patients: a Randomized Clinical Trial Protocol
- ClinicalTrials.gov ID
- NCT02387190
- Acronym / sponsor ID
- RETURN-001 / RETURN-001
- Conditions
- Heart Failure
- Keywords
- Heart Failure, Lung function test, Telenursing, Morbidity, Mortality, Quality of life
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 156 participants (estimated)
- Lead sponsor
- Federal University of BahiaUniversity, hospital or other
- Collaborators
- Fundação de Amparo à Pesquisa do Estado da Bahia
- Study start
- Nov 2013
- Primary completion
- Apr 2015 (actual)
- Study completion
- Mar 2016 (estimated)
- First posted
- 12 Mar 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pulmonary dysfunction presented in patients with heart failure is observed as a decrease of maximal aerobic capacity compared to healthy people. Lung function deterioration manifests, in the presence of muscle fatigue and dyspnea on exertion, loss of functional capacity, and activities limitation of daily living. Those manifestation influence the perception of quality of life of patients1.
Patients with heart failure need to develop changes in lifestyle and daily activities aiming to maintain clinical control and prevent the onset of complications and disabilities. If these changes are not often performed, they might carry bigger burden to for the individual and their family and for the healthcare system due to increasing of morbidity and mortality between those patients2.
Systematic reviews conducted in developed countries (USA3, UK4 and Canada5) and developing countries (Colombia6) have shown that telehealth can produce positive effects in individuals with chronic diseases as heart failure. This kind of intervention seems to be effective in preventing hospitalizations and non-elective emergency visits.
In Brazil, telenursing is still a non-standardized and non-diffused intervention. In this perspective, telenursing represents soft new tools to provide quality care. It certainly allows the orientation and training of patients, the permanence of them at home, reduces unnecessary hospitalization. Additionally, this intervention, allows the management of nursing time and strengthens their professional autonomy7.
The principal aim of this study is to describe the protocol to be used in MRE study. The objective of MRE trial is to test the hypothesis that telenursing contributes to the improvement in lung function over the medium term, in patients with heart failure under continuous education.
Detailed description
METHODS STUDY DESIGN It will be a blinded- controlled-randomized clinical trial in parallel-group, with six months follow-up. The trial protocol will be performed in referral outpatient center that accompany patients with heart failure. This unit is part of the public health system in the city of Salvador - Bahia, the second largest city in Northeast of Brazil. The Brazilian health system is one of the largest public health systems in the world. Ensures full access, universal and free to the entire population of the country. Bolstered by a broader concept of health, the health system was created in 1988 by the Brazilian Federal Constitution, to be the health system of more than 180 million Brazilians.
Run-in
The run-in period will last 15 days. After the run-in, eligible patients will be part of the study, according the following criteria:
- To participate in a telenursing education program;
- To fill-in a diary of symptoms and signs, daily;
- To receive calls from the research team weekly;
- To have attendance at appointment between window of 15 days before or after the scheduled date;
- To be predisposed to performing spirometry testing, six-minute walk test, pulse oximetry, electrocardiography, and to respond questionnaires about quality of life and scales of dyspnoea.
Wash out
After beginning the project, patients who present the following criteria must be excluded:
- Pregnancy;
- Hospitalization for more than 30 days;
- Do not attend monthly visit inside the search window of 15 days before or after the scheduled date;
- To change of residence address among states that preclude attendance at scheduled visits;
- Death;
- To discharge outpatient clinic of the Hospital of study;
- Subsequent diagnostic of acute or chronic respiratory disease or other physical/mental condition that makes it impossible to participate in the study;
- To Cease to participate in telenursingprogram or that study.
RANDOMIZATION
The sample size calculation was performed in Sealed Envelope TM program. 156 patients will be needed (78 per group), using the following indicators: confidence level 95%, 5% maximum error permitted, statistical power of 90% for detecting elevation of the primary endpoint by 12% in the experimental group. After applying the inclusion and exclusion criteria, two groups will be sourced from the randomization and will be allocated into case group and control group without replacement. All subjects included will be assigned a three-digit sequential number (eg. 000-999). These numbers will be fed into groups of four patients with similar characteristics. After that, blok size randomization will be procedure in specific software (www.randomization.com).
INTERVENTIONS The control group will receive standard treatment and monitoring for heart failure from the ambulatory staff where the study will be performed, including pharmacotherapy and health education, as recommended by the health team. The intervention group will receive the standard treatment and ongoing follow-up as well as monitoring by telenursing for a period of 6 months (24 weeks).
The application of remote nursing monitoring program shall establish contact with the participants for six months, through weekly telephone contacts on days and times to be accorded between them. We expected duration of 5 to 10 minutes per call. The team that performs the intervention will explain the content of foreseen contacts with educational approach, allowing the participant a moment to comment and clarification of final questions.
After conclusion of the study, the control group also will receive telenursing intervention if it is proven benefits through this study. The protocol for telenursing intervention deployed can continue in the specialized outpatient clinic and other chronic diseases programs, if proven their benefit.
Implementation of the Program of Telenursing The program of telenursing will consist in weekly contact with patients with heart failure with functional class I, II and III. For the development of telenursing, it will be distributed to the study staff a protocol for remote monitoring practices in nursing and a form of individualized remote monitoring (appendix A and B). Intervention group will be receive educational and support materials (educational booklet and diary of signs and symptoms).
The protocol for telenursing allows the realization of standardized professional contacts with the patient and educational approach It is possible through questions and answers coded, that indicate the need for educational intervention or reinforcement of appropriate health behavior.
The telenursing program protocol is based on: 1) Contact the patient by telephone, weekly; 2) Distribution and explanation of the educational booklet; 3) Filling a diary of symptoms and signs; 4) Record, management and markdown visits in case of non-elective visits, hospitalization or fatal episodes. Also, the following aspects shall be observed: help requests associated with illness, adaptations for living with the disease, effects of drugs in daily life, availability of financial resources for disease management, self-image; emotional and social support.
The protocol is individualized according to the needs identified in the monthly consultation and/or weekly contact for telenursing calls. The protocol addresses the themes: information of health education about the pathology; monitoring the signs and symptoms; adherence to treatment; healthy eating and weight control; breathing exercises; cardiovascular and pulmonary risk factors; physical, occupational and sexual activity; emotional and social support. It functions as a guiding instrument for telenursing, and it is useful in the clinical management of diseases, improvement of self-care, strengthening communication and humanization in relations between professionals and users of health services.
These items will be addressed in alternate calls to avoid wear and loss of information over the phone. Before finalizing the calls, will be offered the individual a moment to express doubts or make other settings regarding the intervention. The nurse is expected to write a report at the end of the calls, by checking the form of individual remote monitoring. All calls will be recorded through Skype and MP3 Skype Recorder software.
The educational booklet containing information about the heart failure and a diary of symptoms and signs will be distributed to the participants, being nurse attribution explain it to them. The booklet developed is a support material for conducting health education by telenursing, illustrated, aimed at answer typical questions, easy to handle and transport, simple visual communication, including to be accessible to individuals with limited understanding of written language. It is a suitable material for the use of the individual as well as the assistance of parents, family members, caregivers and other health professionals and students.
Moreover, after the first contact, will be developed an intervention plan for each individual, according to the needs identified after analysis of medical records and for the nursing consultation. The plan may be modified according to the needs that are identified through the telenursing calls.
Procedures BASELINE: First a baseline period will be held in which, for all individuals enrolled in the study. Following questionnaires will be applied: sociodemographic and clinical characterization formulary; quality of life (Minnesota Living with Heart Failure Questionnaire - MLHFQ); Baseline Dyspnoea Index by Mahler; and electrocardiogram will be performed. When all participants pass through the baseline period, will be preceded randomization and implementation of Visit 01.
Also in this period, a pilot of the telenursing will be made, in which seven study participants will undergo intervention in order to identify necessary changes and adjustments.
VISIT 01 (start of run-in):
For both groups: Application of structured interviews for data collection of socio-demographic and clinical characterization formulary; Application of quality of life questionnaire (MLHFQ); The questionnaire of Baseline Dyspnea Index by Mahler; Conducting pulmonary function test spirometry by a technician certified by the Brazilian Society of Pulmonology; Achievement Test six-minute walk; Measurement of clinical data (pulse oximetry, electrocardiogram, measurement of anthropometric data).
Intervention group: will be explained and distributed a educational booklet and a journal of signs and symptoms. Remote monitoring procedures with nursing continuing education will be explained, collecting best times of contact, collecting phones (personal, neighbors, to run errands, pay phone in the street of residence and mobile phone). On this same visit individuals will be informed of the weekly telephone monitoring and monthly outpatients seen for six months.
Will be provided a standardized health Education for the control group and the intervention group.
VISIT 02, 03, 04, 05:
For both groups: in the days of their regular attendance in the ambulatory will be held: standardized education; reviewed medical clinic (the regular ambulatory); the questionnaires and scales (MLHFQ and Baseline Dyspnoea Index Mahler).
Intervention group: The sessions once a month will be held during the six months of data collection. There will be continuity of telenursing directed to continuing education, weekly.
VISIT 06: all related procedures will be carried out in other visits and additionally walk test six minutes, spirometry, electrocardiogram and pulse oximetry.
ASSESSMENT
- Sphygmomanometer - Brand: Missouri.
- Electrocardiograph - Brand: EMAI - Model: 3-channel, 12 simultaneous leads, Graphic Display: LCD 12.8 x 6.4 cm, 12 Outlets EX03.
- Portable Spirometer for Lung Function Assessment, Brand: KOKO MOE FERRARIS USB.
- Stethoscope - Brand: Missouri
- Pulse Oximeter - Brand: Oxilife, Model: Plus Cmos Drake
- Notebook, Intel Core i5-3210M processor 2.5 GHz, 6GB Memory, 750GB HD, 14-inch LED screen.
- Headphone - Brand: Trust Model: Quasar 16904.
STATISTICAL ANALYSIS PLAN Descriptive statistics will be used to characterize the individuals search. The analysis of continuous variables will be through measures of central tendency and dispersion; categorical variables will be analyzed using proportions. The difference between proportions will be calculated using the chi-square test. Association tests will be performed. For correlations, the Pearson or Spearman tests depending on the normality of information or number of empty cells are proceeded. Additionally, the risk factors are analyzed according to the cutoff score of quality of life. We will use multivariate linear regression to verify association between risk factors and QoL. FIT equations will be done. There will be also analysis by protocol and by intention to treat. Analyzes stratified by age also compose the statistical plan. The information collected will be fed into a database and analyzed using SPSS 20.0 software (Statistical Package for Social Sciences). Statistically significant values with an interval of confidence greater than or equal to 95% will be considered.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Telenursing monitoring | Experimental | Other: Telenursing monitoringThe protocol for telenursing allows the realization of standardized professional contacts with the patient and educational approach It is possible through questions and answers coded, that indicate the need for educational intervention or reinforcement of appropriate health behavior.1) Contact the patient by telephone, weekly; 2) Distribution and explanation of the educational booklet; 3) Filling a diary of symptoms and signs; 4) Record, management and markdown visits in case of non-elective visits, hospitalization or fatal episodes. Also, the following aspects shall be observed: help requests associated with illness, adaptations for living with the disease, effects of drugs in daily life, availability of financial resources for disease management, self-image; emotional and social support. |
| Control group | No intervention | –Placebo is considered as standardized education |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- With prior medical diagnosis of heart failure with functional class I, II or III, in accordance to New York Heart Association (NYRA)8.
- In regular follow-up for at least six months at the study site. Regular follow will be considered when in the period of six months the individual attend at least 2/3 of the scheduled appointments of outpatient unit and 100% of run-in period appointments.
- With dyspnoea or spirometric volumes evidencing deterioration of lung function.
- With cognitive conditions to be interviewed.
- With no medical restrictions to perform spirometry testing and six-minute walk test.
Key exclusion criteria (4 listed)
- With psychiatric disorders;
- Who do not meet eligibility criteria after run-in period;
- With severe acute or chronic pulmonary disease;
- Who change clinical parameters during the data collection (severe dyspnoea, peripherical oxygen saturation below 95%).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Telenursing monitoringThe telenursing program protocol is based on: 1. Contact the patient by telephone, weekly; 2. Distribution and explanation of the educational booklet; 3. Filling a diary of symptoms and signs; 4) Record, management and markdown visits in case of non-elective visits, hospitalization or fatal episodes. Also, the following aspects shall be observed: help requests associated with illness, adaptations for living with the disease, effects of drugs in daily life, availability of financial resources for disease management, self-image; emotional and social support. | Other | Telenursing monitoring |
Primary outcome
Lung function volumes
Time frame: Expected average of 6 months
Evaluation will be done in the V6 compared to V1, only. Baseline has no spirometry test
4 secondary outcomes
Related quality of life
Time frame: Expected average of 6 months
Functional capacity
Time frame: Expected average of 6 months
Morbidity
Time frame: Weekly during telenursing monitoring (Expected average of 6 months)
Mortality
Time frame: Weekly durng telenursing monitoring program (Expected average of 6 months)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2016.
- Background: PubMed 22699730Rodriguez-Gazquez Mde L, Arredondo-Holguin E, Herrera-Cortes R. Effectiveness of an educational program in nursing in the self-care of patients with heart failure: randomized controlled trial. Rev Lat Am Enfermagem. 2012 Mar-Apr;20(2):296-306. doi: 10.1590/s0104-11692012000200012. English, Portuguese, Spanish.
- Background: PubMed 23185992Riley JP, Gabe JP, Cowie MR. Does telemonitoring in heart failure empower patients for self-care? A qualitative study. J Clin Nurs. 2013 Sep;22(17-18):2444-55. doi: 10.1111/j.1365-2702.2012.04294.x. Epub 2012 Nov 27.
Related trials for Heart Failure
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carolina Souza-Machado, PhD study chair
Federal University of Bahia
Carolina Santos, NP principal investigator
Federal University of Bahia
Bárbara Sueli Moreira, NP principal investigator
Federal University of Bahia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Telenursing monitoring in people with Heart Failure, run by Federal University of Bahia at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 12 Feb 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lung function volumes (time frame: Expected average of 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02387190, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2016.